Nexalin Technology (NXL) Cost of Revenue (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Cost of Revenue of $1817.0 for Q1 2026, down 86.6% year-over-year from $13558.0 in Q1 2025, and down 91.36% quarter-over-quarter from $21029.0 in Q4 2025.
Nexalin Technology (NXL) Cost of Revenue (2021 - 2026) Analysis & Trends
Nexalin Technology's Cost of Revenue history runs 6 years deep, the most recent figure standing at $1817.0 for Q1 2026.
- In Q1 2026, Cost of Revenue fell 86.6% year-over-year to $1817.0; the TTM figure through Mar 2026 stood at $49632.0 (up 21.07% YoY), while the FY2025 annual figure was $61373.0, up 67.72% from the prior year.
- Cost of Revenue for Q1 2026 stood at $1817.0, down from $21029.0 in the prior quarter.
- The five-year high for Cost of Revenue was $187298.0 in Q3 2022, with the low at $1817.0 in Q1 2026.
- The 5-year median for Cost of Revenue is $9156.0 (2024), against an average of $28746.1.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue soared 1912.66% in 2022, then sank 97.88% in 2023.
- Nexalin Technology's Cost of Revenue stood at $6867.0 in 2022, then fell by 23.82% to $5231.0 in 2023, then surged by 43.3% to $7496.0 in 2024, then surged by 180.54% to $21029.0 in 2025, then tumbled by 91.36% to $1817.0 in 2026.
- Business Quant data shows NXL's Cost of Revenue at $1817.0 in Q1 2026, $21029.0 in Q4 2025, and $3948.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.99 Bn | 194.39 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.76 Bn | 126.29 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.27 Bn | 111.05 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.67 Bn | 48.42 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.50 Bn | 23.18 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.22 Bn | 22.74 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 3,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,264.00 |
| Jun 30, 2026 | 3,264.00 |
| Mar 31, 2026 | 1,817.00 |
| Mar 31, 2026 | 1,817.00 |
| Dec 31, 2025 | 21,029.00 |
| Dec 31, 2025 | 21,029.00 |
| Sep 30, 2025 | 3,948.00 |
| Sep 30, 2025 | 3,948.00 |
| Jun 30, 2025 | 22,838.00 |
| Jun 30, 2025 | 22,838.00 |
| Mar 31, 2025 | 13,558.00 |
| Mar 31, 2025 | 13,558.00 |
| Dec 31, 2024 | 7,496.00 |
| Dec 31, 2024 | 7,496.00 |
| Sep 30, 2024 | 12,694.00 |
| Sep 30, 2024 | 12,694.00 |
| Jun 30, 2024 | 7,247.00 |
| Jun 30, 2024 | 7,247.00 |
| Mar 31, 2024 | 9,156.00 |
| Mar 31, 2024 | 9,156.00 |